Evidence map›Paper›PMID 37441685›Full record

ArticleFrontiers in medicine2023

Computer-aided diagnosis using embedded ensemble deep learning for multiclass drug-resistant tuberculosis classification.

Kanchana Sethanan, Rapeepan Pitakaso, Thanatkij Srichok, Surajet Khonjun, Nantawatana Weerayuth, Chutinun Prasitpuriprecha, Thanawadee Preeprem, Sirima Suvarnakuta Jantama, Sarayut Gonwirat, Prem Enkvetchakul and 2 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kanchana SethananDepartment of Industrial Engineer, Faculty of Engineering, Research Unit on System Modelling for Industry, Khon Kaen University, Khon Kaen, Thailand.
Rapeepan PitakasoDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Thanatkij SrichokDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Surajet KhonjunDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Nantawatana WeerayuthUbon Ratchathani University, Department of Mechanical Engineer, Faculty of Engineering, Ubon Ratchathani, Thailand.
Chutinun PrasitpuriprechaDivision of Biopharmacy, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Thanawadee PreepremDivision of Biopharmacy, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Sirima Suvarnakuta JantamaUbon Ratchathani University, Division of Biopharmacy, Faculty of Pharmaceutical Sciences, Ubon Ratchathani, Thailand.
Sarayut GonwiratDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Prem EnkvetchakulDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Chutchai KaewtaDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Natthapong NanthasamroengDepartment of Industrial Engineer, Faculty of Engineering, Artificial Intelligence Optimization SMART Laboratory, Ubon Ratchathani University, Ubon Ratchathani, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aims to develop a web application, TB-DRD-CXR, for the categorization of tuberculosis (TB) patients into subgroups based on their level of drug resistance. The application utilizes an ensemble deep learning model that classifies TB strains into five subtypes: drug sensitive tuberculosis (DS-TB), drug resistant TB (DR-TB), multidrug-resistant TB (MDR-TB), pre-extensively drug-resistant TB (pre-XDR-TB), and extensively drug-resistant TB (XDR-TB). Methods: The ensemble deep learning model employed in the TB-DRD-CXR web application incorporates novel fusion techniques, image segmentation, data augmentation, and various learning rate strategies. The performance of the proposed model is compared with state-of-the-art techniques and standard homogeneous CNN architectures documented in the literature. Results: Computational results indicate that the suggested method outperforms existing methods reported in the literature, providing a 4.0%-33.9% increase in accuracy. Moreover, the proposed model demonstrates superior performance compared to standard CNN models, including DenseNet201, NASNetMobile, EfficientNetB7, EfficientNetV2B3, EfficientNetV2M, and ConvNeXtSmall, with accuracy improvements of 28.8%, 93.4%, 2.99%, 48.0%, 4.4%, and 7.6% respectively. Conclusion: The TB-DRD-CXR web application was developed and tested with 33 medical staff. The computational results showed a high accuracy rate of 96.7%, time-based efficiency (ET) of 4.16 goals/minutes, and an overall relative efficiency (ORE) of 100%. The system usability scale (SUS) score of the proposed application is 96.7%, indicating user satisfaction and a likelihood of recommending the TB-DRD-CXR application to others based on previous literature.

Indexed as

artificial multiple intelligence systemcomputer aided diagnosisdrug resistantensemble deep learningtuberculosis

Identifiers

PMID37441685
PMCPMC10333053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.